A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network
暂无分享,去创建一个
[1] David Moher,et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. , 2016, Journal of clinical epidemiology.
[2] Douglas G Altman,et al. Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial , 2015, BMC Medicine.
[3] K. Dickersin,et al. Thomas C Chalmers (1917–1995): a pioneer of randomised clinical trials and systematic reviews , 2015, Journal of the Royal Society of Medicine.
[4] Lotty Hooft,et al. Reporting diagnostic accuracy studies: some improvements after 10 years of STARD. , 2015, Radiology.
[5] D. Moher,et al. Side effects are incompletely reported among systematic reviews in gastroenterology. , 2015, Journal of clinical epidemiology.
[6] Gary S Collins,et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.
[7] James Hartley,et al. Current findings from research on structured abstracts: an update. , 2014, Journal of the Medical Library Association : JMLA.
[8] Gary S Collins,et al. Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study , 2014, BMJ : British Medical Journal.
[9] David Moher,et al. Relation of completeness of reporting of health research to journals’ endorsement of reporting guidelines: systematic review , 2014, BMJ : British Medical Journal.
[10] M. Clarke,et al. Many reports of randomised trials still don’t begin or end with a systematic review of the relevant evidence , 2013 .
[11] R. Prescott,et al. Lies, damn lies and statistics: errors and omission in papers submitted to INJURY 2010-2012. , 2013, Injury.
[12] David Moher,et al. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa , 2012, Systematic Reviews.
[13] J. Achten,et al. An evaluation of the quality of statistical design and analysis of published medical research: results from a systematic survey of general orthopaedic journals , 2012, BMC Medical Research Methodology.
[14] S. Pocock,et al. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. , 2006, JAMA.
[15] G. Piaggio,et al. Consort 2010 statement: extension to cluster randomised trials , 2012, BMJ : British Medical Journal.
[16] Gary S Collins,et al. Reporting of participant flow diagrams in published reports of randomized trials , 2011, Trials.
[17] E. Wagenmakers,et al. Erroneous analyses of interactions in neuroscience: a problem of significance , 2011, Nature Neuroscience.
[18] Iveta Simera,et al. Describing reporting guidelines for health research: a systematic review. , 2011, Journal of clinical epidemiology.
[19] Sally Hopewell,et al. Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed. , 2011, Journal of clinical epidemiology.
[20] I. Cuthill,et al. Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .
[21] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2011, BMJ : British Medical Journal.
[22] J. Sargeant,et al. The REFLECT Statement: Reporting Guidelines for Randomized Controlled Trials in Livestock and Food Safety: Explanation and Elaboration † , 2010, Journal of food protection.
[23] D. Moher,et al. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.
[24] D. Moher,et al. Guidance for Developers of Health Research Reporting Guidelines , 2010, PLoS medicine.
[25] D. Altman,et al. ACP Journal Club. Editorial: Writing a research article that is "fit for purpose": EQUATOR Network and reporting guidelines. , 2009, Annals of internal medicine.
[26] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.
[27] Carl Heneghan,et al. What is missing from descriptions of treatment in trials and reviews? , 2008, BMJ : British Medical Journal.
[28] D. Moher,et al. Guidelines for Reporting Health Research: The EQUATOR Network's Survey of Guideline Authors , 2008, PLoS medicine.
[29] D. Moher,et al. CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration , 2008, PLoS medicine.
[30] T. Wachs,et al. CONSORT for reporting randomised trials in journal and conference abstracts , 2008 .
[31] S. Pocock,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, PLoS medicine.
[32] D. Moher,et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review , 2006, The Medical journal of Australia.
[33] W. Sauerbrei,et al. REporting recommendations for tumor MARKer prognostic studies (REMARK) , 2006, Breast Cancer Research and Treatment.
[34] Dietmar Pfahl,et al. Reporting guidelines for controlled experiments in software engineering , 2005, 2005 International Symposium on Empirical Software Engineering, 2005..
[35] B. Glick. Inadequacies in the reporting of clinical drug research , 1963, Psychiatric Quarterly.
[36] J. Ioannidis,et al. Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement , 2004, Annals of Internal Medicine.
[37] V. McCormack,et al. Issues in the reporting of epidemiological studies: a survey of recent practice , 2004, BMJ : British Medical Journal.
[38] A. Walker,et al. Improving the quality of reporting in randomised controlled trials. , 2004, Journal of wound care.
[39] Douglas G. Altman,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.
[40] David Moher,et al. The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration , 2003, Annals of Internal Medicine [serial online].
[41] Douglas G Altman,et al. Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.
[42] D. Moher,et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.
[43] I. Olkin,et al. Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement , 2000, Oncology Research and Treatment.
[44] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[45] I. Olkin,et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.
[46] I Chalmers,et al. Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents? , 1998, JAMA.
[47] S Dunn,et al. Cargo cult science. , 1996, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[48] I. Olkin,et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.
[49] M. Gardner,et al. More informative abstracts revisited. , 1990, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.
[50] D. Rennie. Reporting randomized controlled trials. An experiment and a call for responses from readers. , 1995, JAMA.
[51] Curtis L. Meinert,et al. A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. , 1994, JAMA.
[52] D G Altman,et al. The scandal of poor medical research , 1994, BMJ.
[53] L. Israels,et al. Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] B. Squires,et al. Reports of randomized controlled trials: what editors want from authors and peer reviewers. , 1990, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[55] D. G. Altman,et al. Randomisation and baseline comparisons in clinical trials , 1990, The Lancet.
[56] J. Ellenberg. Biostatistical collaboration in medical research. , 1990, Biometrics.
[57] M. Zelen. The reporting of clinical trials: counting is not easy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] A. Grant,et al. Reporting controlled trials , 1989, British journal of obstetrics and gynaecology.
[59] P. Gøtzsche. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. , 1989, Controlled clinical trials.
[60] S. Pocock,et al. Statistical problems in the reporting of clinical trials. A survey of three medical journals. , 1987, The New England journal of medicine.
[61] F. Gutzwiller,et al. A proposal for more informative abstracts of clinical articles. Ad Hoc Working Group for Critical Appraisal of the Medical Literature. , 1987, Annals of internal medicine.
[62] A Liberati,et al. A quality assessment of randomized control trials of primary treatment of breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] C. Meinert,et al. Content of reports on clinical trials: a critical review. , 1984, Controlled clinical trials.
[64] S G Mize,et al. An Evaluation of the Quality of Therapeutic Studies in Perinatal Medicine , 1983, The Journal of pediatrics.
[65] Frederick Mosteller,et al. Reporting on methods in clinical trials. , 1982, The New England journal of medicine.
[66] T. Colton,et al. Should there be statistical guidelines for medical research papers? , 1978, Biometrics.
[67] D. Laskin. The problems of publication. , 1977, Journal of oral surgery.
[68] A R Feinstein,et al. XXV. A survey of the statistical procedures in general medical journals , 1974, Clinical pharmacology and therapeutics.
[69] D. Mainland. Some research terms for beginners: definitions, comments, and examples. I. , 1969, Clinical pharmacology and therapeutics.
[70] S. Schor,et al. Statistical evaluation of medical journal manuscripts. , 1966, JAMA.
[71] A. P. Shapiro,et al. The clinical evaluation of new drugs , 1960 .
[72] H. L. Dunn. What high-level wellness means. , 1959, Canadian journal of public health = Revue canadienne de sante publique.
[73] S. Ross,et al. RECOMMENDATIONS for reporting studies of psychiatric drugs. , 1957, Public health reports.
[74] D. Mainland,et al. Elementary Medical Statistics. The Principles of Quantitative Medicine. , 1952 .
[75] O B ROSS,et al. Use of controls in medical research. , 1951, Journal of the American Medical Association.
[76] L. Hogben,et al. Chance and choice by cardpack and chessboard , 1950 .
[77] M. Daniels. Scientific appraisement of new drugs in tuberculosis. , 1950, American review of tuberculosis.
[78] J. Berkson. The Treatment of Clinical and Laboratory Data , 1939 .
[79] D. Mainland. CHANCE AND THE BLOOD COUNT. , 1934, Canadian Medical Association journal.
[80] B. Hart. WHAT IS WRONG WITH THE MEDICAL CURRICULUM , 1932 .
[81] H. L. Dunn,et al. APPLICATION OF STATISTICAL METHODS IN PHYSIOLOGY , 1929 .
[82] R. Pearl. A STATISTICAL DISCUSSION OF THE RELATIVE EFFICACY OF DIFFERENT METHODS OF TREATING PNEUMONIA , 1919 .
[83] T. Sollmann. THE CRUCIAL TEST OF THERAPEUTIC EVIDENCE , 1917 .